Individual case safety reports in children in commonly used drug groups – signal detection
Open Access
- 17 March 2008
- journal article
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 8 (1) , 1
Abstract
Background: Due to few paediatric drug safety studies, knowledge on risks of drug treatment in children is limited. The knowledge needs to be increased to make proper risk-benefit analyses possible when treating paediatric patients with drugs. The aim of the present study was to investigate drug groups commonly used in children concerning type and frequency of individual case safety reports in children. Methods: Number and type of individual case safety reports in the 30 groups of drugs (5th level ATC-code) most sold (number of defined daily doses) in outpatient treatment to children (<15 years old) during 2005 were obtained. Descriptive analyses of the adverse drug reactions reported in children were performed. Results: The number of individual case safety reports per million defined daily doses in children varied in the groups of drug between 0 and 24. The largest number was found in the drug group R03DC, the leukotriene receptor antagonist montelukast; the majority of the children being <5 years old and experiencing psychiatric adverse drug reactions. Conclusion: The number of individual case safety reports per million defined daily doses varies in different groups of drugs. A possible signal for montelukast and psychiatric adverse drug reactions was found, which should be further explored.Keywords
This publication has 14 references indexed in Scilit:
- Drug related problems and off-label drug treatment in children as seen at a drug information centreEuropean Journal of Pediatrics, 2006
- Paediatric adverse drug reactions reported in Sweden from 1987 to 2001Pharmacoepidemiology and Drug Safety, 2005
- Under‐reporting of serious adverse drug reactions in SwedenPharmacoepidemiology and Drug Safety, 2004
- Adverse drug reactions and off‐label prescribing for paediatric outpatients: a one‐year survey of spontaneous reports in SwedenPharmacoepidemiology and Drug Safety, 2003
- Adverse drug reactions and off-label drug use in paediatric outpatientsBritish Journal of Clinical Pharmacology, 2002
- Reported Adverse Drug Events in Infants and Children Under 2 Years of AgePediatrics, 2002
- Adverse drug reactions as a cause for admissions to a department of internal medicinePharmacoepidemiology and Drug Safety, 2002
- Incidence of adverse drug reactions in paediatric in/out‐patients: a systematic review and meta‐analysis of prospective studiesBritish Journal of Clinical Pharmacology, 2001
- Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective studyActa Paediatrica, 1999
- Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric useBritish Journal of Clinical Pharmacology, 1999